The University of Maryland-Medicine Institute for Neuroscience Discovery (UM-MIND) furthers translational research of the brain by facilitating interaction between basic and clinical scientists and enhancing collaborative research across the University of Maryland, Baltimore campus.
The Research Initiative in Infectious Disease and Substance Use (RIIS), a community-based clinical care and research program within Institute of Human Virology (IHV) that explores the intersection of infections and substance use in marginalized populations.
The Maryland Addiction Consultation Service (MACS), a state-sponsored program administered by UMSOM. MACS provides support to prescribers and their practices, pharmacists, and healthcare teams in addressing the needs of patients with substance use disorders and chronic pain management.
The Maryland Psychiatric Research Center (MPRC) is an internationally renowned research center, which is dedicated to providing treatment to patients with schizophrenia and related disorders, educating professionals and consumers about schizophrenia, and conducting basic and translational research into the manifestations, causes, and treatment of schizophrenia.
UMSOM’s Center for Substance Use in Pregnancy, a research center that studies the long-term health effects on the brains of children born to people who use drugs and alcohol during pregnancy.
The Center for Addiction Medicine (CAM) at the University of Maryland Medical Center Midtown Campus, a comprehensive clinical program offering medication-assisted treatment and outpatient counseling.
The University of Maryland Institute for Health Computing, a medical research and academic institute that uses artificial intelligence (AI), virtual reality, precision medicine, and other emerging technologies to diagnose, prevent, and treat diseases in patients across Maryland.